Product Information

OLANZAPINE-FLUOXETINE 12-25 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $9.8134 per EA under NDC 00093550656. Its NADAC has been published 327 times since Jan 22, 2014.

FDA first approved this application on Jun 19, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLANZAPINE-FLUOXETINE 12-25 MG

Olanzapine and Fluoxetine
$9.8134per EA

Strength

25; 12 mg/1; mg/1

NDC

00093550656

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077528

FDA Approved

6/19/2012

TE Code

AB

On Market Since

6/19/2012

Pharmacological Classes

Price Statistics

The NADAC for OLANZAPINE-FLUOXETINE 12-25 MG has been published 327 times since Jan 22, 2014, and over the history we have for it it has declined 41.3%. The table below summarizes its recorded NADAC range and movement.

Current price$9.8134 per EA
All-time high$17.0031 (Aug 13, 2014)
All-time low$6.2827 (Jul 23, 2025)
52-week high$9.8134
52-week low$6.6089
Median price$13.1290
Average price$11.6424
Largest weekly change-48.9% (Dec 19, 2018)
Weeks tracked327
Tracking sinceJan 22, 2014

Price History

1W

+1.2%

1M

+1.2%

3M

+6.4%

6M

+37.4%

1Y

+48.5%

3Y

+46.2%

5Y

+46.2%

All

-41.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Olanzapine and Fluoxetine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OLANZAPINE-FLUOXETINE 12-25 MG?

The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 12-25 MG, manufactured by Teva Pharmaceuticals USA Inc., is $9.8134 per EA (NDC 00093550656), effective Aug 19, 2026.

How has the price of OLANZAPINE-FLUOXETINE 12-25 MG changed over time?

Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 12-25 MG has declined 41.3%. It has been tracked across 327 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 12-25 MG?

Since Jan 22, 2014, the NADAC for OLANZAPINE-FLUOXETINE 12-25 MG has ranged from a low of $6.2827 (Jul 23, 2025) to a high of $17.0031 (Aug 13, 2014), with a median of $13.1290 per EA.

Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 12-25 MG?

No other NADAC-published product currently shares the active ingredient and strength of OLANZAPINE-FLUOXETINE 12-25 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLANZAPINE-FLUOXETINE 12-25 MG?

OLANZAPINE-FLUOXETINE 12-25 MG (NDC 00093550656) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.